The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The End of the Beginning: COVID-19 Vaccines & Other Conundrums

The End of the Beginning: COVID-19 Vaccines & Other Conundrums

December 9, 2020 • By Philip Seo, MD, MHS

  • Tweet
  • Email
Print-Friendly Version / Save PDF

That still leaves 18%—59 million Americans—who have no interest in the vaccine. Who are these people, and can their minds be changed?

You Might Also Like
  • ACR Convergence 2020: Progress Toward COVID-19 Vaccines
  • COVID-19 Immunization Day: It Won’t Be Long Before We Can Hug Again
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
Also By This Author
  • Thinking Big, Thinking Small

Trekkies & Trekkers
First, a lesson on nomenclature: anti-vaxxer is to vaccine hesitant as trekkie is to trekker. Both sets of terms refer to roughly similar groups of people, but there is nuance. The anti-vaxxers are the true believers; they will not be swayed by mere PowerPoint presentations. They will match you, slide for slide, with offbeat interpretations of questionable studies and nonsensical assertions of individual freedoms. They are like those who refuse to acknowledge the brilliance of Ricardo Montalbán’s performance in Star Trek II: Wrath of Khan. They are beyond hope or reason.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The vaccine hesitant comprise the reasonable reverse of the same coin. They do not doubt the science supporting the use of vaccines. They know that vaccines save lives. They’re just afraid. Or indifferent.16

The vaccine hesitant largely fall into three categories. The first is the hale and hearty, who largely think of COVID-19 as a problem for other people. They may even have friends who, also young and healthy, may have tested positive without ever having realized they were ill, which reinforces their viewpoint. The second category is ethnic minorities, who may not interact with the healthcare system on a regular basis or may bear some suspicion of organized healthcare, in general. The third category is the hyperinformed, the patients who show up to appointments with their Google searches and preprints, asking endless questions that have no good answer.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Sound like anyone you know?

I haven’t yet had many of these difficult conversations, but I know they are coming. And we should acknowledge they have a point. The history of vaccine rollouts has not been without tragedy. The worst example was the 1955 Cutter Incident, in which a manufacturing error allowed live polio to be mixed with the inactivated vaccine.17 The flawed vaccine sickened 40,000 children; 51 of these children were paralyzed, and five died. Even then, the company was not found to be negligent; a jury found it did the best it could with a novel, complex manufacturing process.

To reach the vaccine hesitant, we need to address their concerns head-on. For the unworried well, we need to convince them that getting vaccinated is an act of altruism, somewhere between running into a burning building and helping a little old lady cross the street. It is the young and healthy who are most likely to have an asymptomatic or minimally symptomatic infection, which they can unknowingly transmit to others. They may not benefit directly from the vaccine, but vaccination may prevent them from inadvertently infecting someone they love.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Rheuminations Tagged With: COVID-19

You Might Also Like:
  • ACR Convergence 2020: Progress Toward COVID-19 Vaccines
  • COVID-19 Immunization Day: It Won’t Be Long Before We Can Hug Again
  • ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
  • Early Lessons from the COVID-19 Pandemic: A Q&A with Chris Phillips, MD

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.